Business Description
Vor Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US9290331084
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.85 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | -0.29 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -13.9 | |||||
3-Year EPS without NRI Growth Rate | -11.8 | |||||
3-Year FCF Growth Rate | -8.9 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.35 | |||||
9-Day RSI | 35.98 | |||||
14-Day RSI | 38.51 | |||||
6-1 Month Momentum % | 0.47 | |||||
12-1 Month Momentum % | -51.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.04 | |||||
Quick Ratio | 9.04 | |||||
Cash Ratio | 8.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.1 | |||||
Shareholder Yield % | -3.57 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -58.3 | |||||
ROA % | -47.18 | |||||
ROIC % | -186.43 | |||||
ROC (Joel Greenblatt) % | -234.61 | |||||
ROCE % | -53.42 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.76 | |||||
Price-to-Tangible-Book | 0.76 | |||||
EV-to-EBIT | -0.11 | |||||
EV-to-EBITDA | -0.12 | |||||
EV-to-FCF | -0.14 | |||||
Price-to-Net-Current-Asset-Value | 1.22 | |||||
Price-to-Net-Cash | 1.28 | |||||
Earnings Yield (Greenblatt) % | -909.09 | |||||
FCF Yield % | -87.92 |